Track topics on Twitter Track topics that are important to you
Chris Carpenter has been appointed chief medical officer of Cambridge, MA-based Rubius Therapeutics. Carpenter was most recently senior vice president and head of the cancer epigenetics department at GlaxoSmithKline (NYSE: GSK). His experience also includes posts at Merck (NYSE: MRK) and Harvard Medical School. Earlier this year, Rubius raised $125 million to bring its engineered […]
Original Article: GSK’s Chris Carpenter Joins Rubius as Chief Medical OfficerNEXT ARTICLE
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...